Tag - therapeutics

The Role of the Human Gut Microbiome in Alzheimer’s Disease Development

Velsera Is Building an Ecosystem that Accelerates the R&D Loop and Democratizes Omics Data to Propel the Next Era of Precision Medicine

Deepcell Aims to Create a Single Cell Morpholome Platform

Enlightenbio Releases New Report – Database of Biomarkers Curated from US Oncology Trials

Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase Equity and Improve Outcomes for Families Impacted by Genetic Disease

FAIR Data or the Journey Towards Data-Centricity – Pushing Towards Making Data Discoverable, Accessible, Interoperable, and Reusable

Seven Bridges Announces Initial Close of Series C Funding from New Strategic Investor to Accelerate Product Development and Commercial Growth

Genomics plc completes oversubscribed $30M funding round

Tempus Launches Hereditary Cancer Germline Assay, xG

Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle

My Gene Counsel and Genomet Announce Product Partnership to Transform Cancer Care Around the Globe

UK Biobank launches one of the largest scientific studies measuring circulating proteins, to better understand the link between genetics and human disease

Life of a Clinical Geneticist: Dealing Often With Heartless Bureaucracy

Mike Pellini, Section 32: “I hope we will find a way where the payers and the healthcare industry will work much more closely together to generate the data that will ultimately be useful in answering difficult, cost-based decisions.”

Copyright © 2023. enlighenbio LLC. All rights reserved.